ライフサイエンスコーパス: hypopituitarism

1 ncluding development of treatment-associated hypopituitarism).

2 nd TSH and a relatively rapid development of hypopituitarism.

3 requires hormone replacement for persistent hypopituitarism.

4 nsity in hypogonadal men, including men with hypopituitarism.

5 (21.1%) commenced hormone replacement(s) for hypopituitarism.

6 obstructive lung disease, other cancers, and hypopituitarism.

7 is still developmentally delayed and now has hypopituitarism.

8 with AM, sometimes with poly/syndactyly and hypopituitarism.

9 ound visual loss, ocular motor deficits, and hypopituitarism.

10 nd specific-cause mortality in patients with hypopituitarism.

11 dary to chronic malnutrition, and idiopathic hypopituitarism.

12 ntiation of hormone-producing cells, causing hypopituitarism.

13 the predictable but slowly evolving forms of hypopituitarism.

14 inated by this screen that co-segregate with hypopituitarism.

15 idline cerebral defects, which may result in hypopituitarism.

16 and provide support for a digenic basis for hypopituitarism.

17 g cytotoxic drugs do not often develop overt hypopituitarism, although the effect of radiotherapy mig

18 ion of Septo-Optic Dysplasia (SOD) including hypopituitarism and Cardio-Facio-Cutaneous (CFC) syndrom

19 s, visual complications, diabetes insipidus, hypopituitarism and cranial nerve injury.

20 al implications for understanding congenital hypopituitarism and craniofacial anomalies.

21 ait disturbance, visual impairment, anterior hypopituitarism and hair anomalies.

22 oxytocin deficiency (OXT-D) in patients with hypopituitarism and hypothalamic damage (HHD), that migh

23 ranscription factor SOX3 are associated with hypopituitarism and mental retardation, but nothing is k

24 The association between hypopituitarism and metabolic dysfunction-associated ste

25 ologists dealing with patients who have both hypopituitarism and neurological diseases.

26 ssive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunct

27 We identified two children with neonatal hypopituitarism and thin pituitary stalk who were doubly

28 adenomas additionally require evaluation for hypopituitarism, and patients with tumors compressing th

29 Mass effects cause headache, hypopituitarism, and visual field defects.

30 cause an early infantile encephalopathy with hypopituitarism as the leading presentation, and expand

31 An 8-year-old with hypopituitarism-associated metabolic dysfunction-associa

32 sed morbidity and mortality in patients with hypopituitarism; availability of highly efficacious, eas

33 Congenital hypopituitarism (CH) is characterized by the deficiency

34 uitary gland in humans results in congenital hypopituitarism (CH).

35 ients) in those given pembrolizumab 2 mg/kg; hypopituitarism, colitis, diarrhoea, decreased appetite,

36 Patients with hypopituitarism develop a phenotype similar to metabolic

37 p 1014 UK patients (514 men, 500 women) with hypopituitarism from January, 1992, to January, 2000.

38 e excess as well as visual field defects and hypopituitarism from mass effect in larger tumors.

39 sed from the HypoCCS database of adults with hypopituitarism from the USA, Canada, Japan, and 14 Euro

40 Patients with hypopituitarism have complex endocrine deficiencies, and

41 Patients with hypopituitarism have excess mortality, predominantly fro

42 , hypothyroidism (HR, 3.8; 95% CI, 2.4-6.1), hypopituitarism (HR, 19.8; 95% CI, 5.4-72.9), other pitu

43 FOXA2 in a complex congenital syndrome with hypopituitarism, hyperinsulinism and endoderm-derived or

44 to examine the clinical associations between hypopituitarism, hypothalamic dysfunction, and nonalcoho

45 ts seen at our institution with diagnoses of hypopituitarism, hypothalamic obesity, or craniopharyngi

46 MRI are sensitive and specific indicators of hypopituitarism in children with ONH.

47 resonance imaging (MRI) for the detection of hypopituitarism in children with ONH.

48 It is essential to identify hypopituitarism in children with optic nerve hypoplasia

49 ause in a group of patients characterized by hypopituitarism in combination with brain atrophy, thin

50 2 (SOX2) haploinsufficiency causes a form of hypopituitarism in humans that is characterized by gonad

51 ations in PROP1 are the most common cause of hypopituitarism in humans; therefore, unraveling its mec

52 Congenital hypopituitarism is a deficiency in one or more pituitary

53 Congenital hypopituitarism is a genetically heterogeneous condition

54 Hypopituitarism is associated with excess mortality, a k

55 The severity and rate of development of hypopituitarism is determined by the dose of radiotherap

56 Hypopituitarism is diagnosed based on baseline blood sam

57 Hypopituitarism is rare and likely to be underdiagnosed,

58 ;Hesx1Cre/+ compound embryos indicates that hypopituitarism is the likely cause of these defects sin

59 roidism, hyperthyroidism, thyroid neoplasms, hypopituitarism, obesity, diabetes mellitus, or gonadal

60 xcluded if they were pregnant, had diagnosed hypopituitarism or hyperthyroidism, or had a medical con

61 onsiderable morbidity due to local invasion, hypopituitarism, or hormone hypersecretion.

62 ne supplementation in adrenal insufficiency, hypopituitarism, osteoporosis, systemic lupus erythemato

63 Post-traumatic hypopituitarism (PTHP) can have major consequences for p

64 Hypopituitarism refers to deficiency of one or more horm

65 abnormalities in 27 of the 28 children with hypopituitarism (sensitivity, 96%).

66 sense variants in unrelated individuals with hypopituitarism that were predicted to affect a minor is

67 cancer can cause autoimmune hypophysitis and hypopituitarism; therefore, oncologists and endocrinolog

68 s one of the youngest reported children with hypopituitarism to have undergone transplantation for ra

69 of second-generation antiepileptic drugs on hypopituitarism treatment.

70 Past or present clinical signs of hypopituitarism were rare, occurring in 3 patients (4.6%

71 ion of the pituitary gland causes iatrogenic hypopituitarism which requires lifelong hormonal supplem

72 ch as visual field defects, headache, and/or hypopituitarism, which occur in about 18% to 78%, 17% to

73 describe an individual with cleft palate and hypopituitarism who harbors a nucleotide variant in the

74 eported premature mortality in patients with hypopituitarism with standard mortality ratios (SMRs) va

75 An additional phenotype of hypopituitarism, with anterior pituitary hypoplasia and

76 fective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavag